Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MedImmune Expects Initial Data From Head-To-Head Numax/Synagis Trial Before Nov. 23

Oct 26 2006

• By Shirley Haley

Related Content

Merck’s Gardasil Records $70 Mil. In Sales In Q3

Oct 20 2006

Cervarix Filing Delay Will Not Impact The HPV Vaccine’s Market Potential – GSK

Oct 26 2006

MedImmune Puts FluMist In FDA's Fridge

Aug 14 2006

MedImmune To Release Phase III Data By Year-End For Synagis Follow-On

Jul 21 2006

Refrigerator-Stable FluMist Submitted For Young Children

Jul 31 2006

Declaratory Judgment Ruling From U.S. Supreme Court Could Impact Licensing Deals, ANDAs

Oct 10 2006

Amgen Expands Inflammation Pipeline With Avidia Purchase

Sep 29 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window